1 |
Cho, S. W., Lee, H. S,. 2022. A Study on the Common RPN Model of Failure Mode Evaluation Analysis(FMEA) and its Application for Risk Factor Evaluation. Journal of Korean Society for Quality Management 50(1):125-138.
DOI
|
2 |
George L. Reid,. James Morgado. 2013. Analytical Quality by Design (AQbD) in Pharmaceutical Development. American Pharmaceutical Review. August 27.
|
3 |
Helen Yarovoi., Tina Frey. 2013. Quality by design for a vaccine release immunoassay : a case study. Bioanalysis 5(20):2531-2545.
DOI
|
4 |
ICH Guideline Q10. Pharmaceutical Quality System.
|
5 |
ICH Guideline Q11. Development and Manufacture of Drug Substances.
|
6 |
ICH Guideline Q8. Pharmaceutical Development.
|
7 |
ICH Guideline Q9. Quality Risk Management.
|
8 |
Kim, K. H. 2018. A Study on problem solving methodology suitable for field and innovation specialists -Focusing on L Company Six Sigma activities, Doctoral dissertation in business administration.
|
9 |
Kim, K. H., and Kim, H. J., 2022. A study on the build of a QbD six sigma system to promote quality improvement(QbD) based on drug design. Journal of the Korean Society for Quality Management 50(3):373-386.
|
10 |
Kim, K. H., and Ree, S. B., 2017. A Study on the Development of the Key Promoting Talent in the 4th Industrial Revolution - Utilizing Six Sigma MBB competency. Journal of the Korean Society for Quality Management 45(4):677-695.
DOI
|
11 |
Kim, K. H., and Ree, S. B., 2017. Suggested Shiny-Sigma method suitable for the shop floor. Journal of the Korean Society for Quality Management 45(2):227-246.
DOI
|
12 |
Kim, K. H., and Ree, S. B., 2020. A Case Study on QbD-6 sigma Method to the Pharmaceutical Department of L Company. ICIC Express Letters, Part B: Applications 11(5):501-508.
|
13 |
Lawrence, Y., 2018 Six Sigma Quality and Consortia. Pharmaceutical Engineering 38(6):8-10.
|
14 |
Lee, Y. G., Lee, H. J., 2021. Development of a New Similarity Index to Compare Time-series Profile Data for Animal and Human Experiments. Journal of Korean Society for Quality Management 49(2):145-159.
DOI
|
15 |
Seo, H. J,. Byun, J. H., 2021. Quality 4.0: Concept, Elements, Level Evaluation and Deployment Direction. Journal of Korean Society for Quality Management 49(4):447-466.
DOI
|
16 |
USP1033 Biological Assay Validation.
|
17 |
USP1034 Analysis of Biological Assays.
|
18 |
Yim, H. S., 2018. Field of pharmaceutical bio industry. NeHa.
|